Inhibrx Biosciences, Inc.INBXNASDAQ
LOADING
|||
Operating Income Contraction
Trending lower, below historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-331.45M
↓ 221% below average
Average (8y)
$-103.21M
Historical baseline
Range
High:$-12.15M
Low:$-331.45M
CAGR
+51.2%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-331.45M | -51.2% |
| 2023 | $-219.22M | -69.8% |
| 2022 | $-129.12M | -68.6% |
| 2021 | $-76.56M | -13.5% |
| 2020 | $-67.44M | -54.3% |
| 2019 | $-43.71M | -48.1% |
| 2018 | $-29.51M | -49.6% |
| 2017 | $-19.73M | -62.4% |
| 2016 | $-12.15M | - |